The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes
Open accessAbstract
Achieving efficient in vivo delivery of siRNA to the appropriate target cell would be a major advance in the use of RNAi in gene function studies and as a therapeutic modality. Hepatocytes, the key parenchymal cells of the liver, are a particularly attractive target cell type for siRNA delivery given their central role in several infectious and metabolic disorders. We have developed a vehicle for the delivery of siRNA to hepatocytes both in vitro and in vivo , which we have named siRNA Dynamic PolyConjugates. Key features of the Dynamic PolyConjugate technology include a membrane-active polymer, the ability to reversibly mask the activity of this polymer until it reaches the acidic environment of endosomes, and the ability to target this modified polymer and its siRNA cargo specifically to hepatocytes in vivo after simple, low-pressure i.v. injection. Using this delivery technology, we demonstrate effective knockdown of two endogenous genes in mouse liver: apolipoprotein B ( apoB ) and peroxisome proliferator-activated receptor alpha ( ppara ). Knockdown of apoB resulted in clear phenotypic changes that included a significant reduction in serum cholesterol and increased fat accumulation in the liver, consistent with the known functions of apoB . Knockdown of ppara also resulted in a phenotype consistent with its known function, although with less penetrance than observed in apoB knockdown mice. Analyses of serum liver enzyme and cytokine levels in treated mice indicated that the siRNA Dynamic PolyConjugate was nontoxic and well tolerated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., Donoghue, M., Elbashir, S., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,183
Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways
Grimm, D., Streetz, K. L., Jopling, C. L., Storm, T. A., Pandey, K., Davis, C. R., Marion, P., Salazar, F., & Kay, M. A. (2006) · Nature · doi:10.1038/nature04791 · Cited by 1,677
Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting
Kersten, S., Seydoux, J., Peters, J. M., Gonzalez, F. J., Desvergne, B., & Wahli, W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6223 · Cited by 1,649
The Liver: Biology and Pathobiology.
(1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-5-690_3 · Cited by 1,590
RNAi-mediated gene silencing in non-human primates
Zimmermann, T. S., Lee, A. C. H., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., et al. (2006) · Nature · doi:10.1038/nature04688 · Cited by 1,357
Schoonjans, K., Staels, B., & Auwerx, J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42003-6 · Cited by 1,216
Strategies for silencing human disease using RNA interference
Kim, D. H., & Rossi, J. J. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2006 · Cited by 1,078
RNA interference in adult mice
McCaffrey, A. P., Meuse, L., Pham, T.-T. T., Conklin, D. S., Hannon, G. J., & Kay, M. A. (2002) · Nature · doi:10.1038/418038a · Cited by 1,059
Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors
Song, E., Zhu, P., Lee, S.-K., Chowdhury, D., Kussman, S., Dykxhoorn, D. M., Feng, Y., Palliser, D., Weiner, D. B., Shankar, P., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1101 · Cited by 1,021
DUFES, C., UCHEGBU, I., & SCHATZLEIN, A. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.017 · Cited by 984
Schiffelers, R. M. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh140 · Cited by 901
siRNA-mediated gene silencing in vitro and in vivo
Xia, H., Mao, Q., Paulson, H. L., & Davidson, B. L. (2002) · Nature Biotechnology · doi:10.1038/nbt739 · Cited by 873
Welt, F. G. P., & Edelman, E. R. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)90003-x · Cited by 863
Position-specific chemical modification of siRNAs reduces “off-target” transcript silencing
Jackson, A. L., Burchard, J., Leake, D., Reynolds, A., Schelter, J., Guo, J., Johnson, J. M., Lim, L., Karpilow, J., Nichols, K., et al. (2006) · RNA · doi:10.1261/rna.30706 · Cited by 789
Inhibition of respiratory viruses by nasally administered siRNA
Bitko, V., Musiyenko, A., Shulyayeva, O., & Barik, S. (2005) · Nature Medicine · doi:10.1038/nm1164 · Cited by 725
Urban-Klein, B., Werth, S., Abuharbeid, S., Czubayko, F., & Aigner, A. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302425 · Cited by 716
Progress towards in Vivo Use of siRNAs
Behlke, M. A. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.01.001 · Cited by 677
Design of Noninflammatory Synthetic siRNA Mediating Potent Gene Silencing in Vivo
Judge, A. D., Bola, G., Lee, A. C. H., & MacLachlan, I. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.11.002 · Cited by 571
Hu-Lieskovan, S., Heidel, J. D., Bartlett, D. W., Davis, M. E., & Triche, T. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0565 · Cited by 567
Efficient delivery of siRNA for inhibition of gene expression in postnatal mice
Lewis, D. L., Hagstrom, J. E., Loomis, A. G., Wolff, J. A., & Herweijer, H. (2002) · Nature Genetics · doi:10.1038/ng944 · Cited by 546
Self-citationThe Liver: Biology and Pathobiology
Worman, H. J. (1995) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(95)70120-6 · Cited by 541
Tiscornia, G., Singer, O., Ikawa, M., & Verma, I. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437912100 · Cited by 540
Inhibition of influenza virus production in virus-infected mice by RNA interference
Ge, Q., Filip, L., Bai, A., Nguyen, T., Eisen, H. N., & Chen, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402486101 · Cited by 444
Lieber, A., He, C. Y., Meuse, L., Schowalter, D., Kirillova, I., Winther, B., & Kay, M. A. (1997) · Journal of Virology · doi:10.1128/jvi.71.11.8798-8807.1997 · Cited by 412
Zhang, W., Yang, H., Kong, X., Mohapatra, S., Juan-Vergara, H. S., Hellermann, G., Behera, S., Singam, R., Lockey, R. F., & Mohapatra, S. S. (2005) · Nature Medicine · doi:10.1038/nm1174 · Cited by 365
Minakuchi, Y. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh093 · Cited by 336
Role of the Kupffer Cell in Mediating Hepatic Toxicity and Carcinogenesis
Roberts, R. A., Ganey, P. E., Ju, C., Kamendulis, L. M., Rusyn, I., & Klaunig, J. E. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl173 · Cited by 331
The silent treatment: siRNAs as small molecule drugs
Dykxhoorn, D. M., Palliser, D., & Lieberman, J. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302703 · Cited by 324
Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication†
Morrissey, D. V., Blanchard, K., Shaw, L., Jensen, K., Lockridge, J. A., Dickinson, B., McSwiggen, J. A., Vargeese, C., Bowman, K., Shaffer, C. S., et al. (2005) · Hepatology · doi:10.1002/hep.20702 · Cited by 290
Cationic liposome-mediated delivery of siRNAs in adult mice
Sioud, M., & Sørensen, D. R. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.057 · Cited by 286
Synthesis and function of hepatic very-low-density lipoprotein
Gibbons, G. F., Wiggins, D., Brown, A.-M., & Hebbachi, A.-M. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320059 · Cited by 254
Crooke, R. M., Graham, M. J., Lemonidis, K. M., Whipple, C. P., Koo, S., & Perera, R. J. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400492-jlr200 · Cited by 225
Hassani, Z., Lemkine, G. F., Erbacher, P., Palmier, K., Alfama, G., Giovannangeli, C., Behr, J.-P., & Demeneix, B. A. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.659 · Cited by 198
Targeting hepatocytes for drug and gene delivery emerging novel approaches and applications
Wu, J. (2002) · Frontiers in Bioscience · doi:10.2741/a806 · Cited by 190
Endosomolysis by Masking of a Membrane-Active Agent (EMMA) for Cytoplasmic Release of Macromolecules
Rozema, D. B., Ekena, K., Lewis, D. L., Loomis, A. G., & Wolff, J. A. (2003) · Bioconjugate Chemistry · doi:10.1021/bc0255945 · Cited by 161
Self-citationTwo categories of mammalian galactose-binding receptors distinguished by glycan array profiling
Coombs, P. J., Taylor, M. E., & Drickamer, K. (2006) · Glycobiology · doi:10.1093/glycob/cwj126 · Cited by 158
Poly(ethylene glycol) Conjugated Drugs and Prodrugs: A Comprehensive Review
Greenwald, R. B., Conover, C. D., & Choe, Y. H. (2000) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v17.i2.20 · Cited by 133
The binding site of rabbit hepatic lectin.
Sarkar, M., Liao, J., Kabat, E. A., Tanabe, T., & Ashwell, G. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50739-0 · Cited by 105
Inflammatory responses to lipopolysaccharide are suppressed in 40% energy-restricted mice
Matsuzaki, J., Kuwamura, M., Yamaji, R., Inui, H., & Nakano, Y. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.8.2139 · Cited by 94
Jansen, R. W., Molema, G., Ching, T. L., Oosting, R., Harms, G., Moolenaar, F., Hardonk, M. J., & Meijer, D. K. F. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)49994-2 · Cited by 88
Snoeys, J., Lievens, J., Wisse, E., Jacobs, F., Duimel, H., Collen, D., Frederik, P. M., & Geest, B. D. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302899 · Cited by 87
Popielarski, S. R., Hu‐Lieskovan, S., French, S. W., Triche, T. J., & Davis, M. E. (2005) · Bioconjugate Chemistry · doi:10.1021/bc0501146 · Cited by 84
Design and Creation of New Nanomaterials for Therapeutic RNAi
Baigude, H., McCarroll, J. A., Yang, C., Swain, P. M., & Rana, T. M. (2007) · ACS Chemical Biology · doi:10.1021/cb7000582 · Cited by 80
Chen, Z., Fitzgerald, R. L., Averna, M. R., & Schonfeld, G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004913200 · Cited by 77
Schonfeld, G. (1995) · Annual Review of Nutrition · doi:10.1146/annurev.nu.15.070195.000323 · Cited by 76
Biessen, E. A. L., Bakkeren, H. F., Beuting, D. M., Kuiper, J., & van Berkel, T. J. C. (1994) · Biochemical Journal · doi:10.1042/bj2990291 · Cited by 58
Apolipoprotein B Metabolism: Tracer Kinetics, Models, and Metabolic Studies
Burnett, J. R., & Barrett, P. H. R. (2002) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360208951113 · Cited by 54
Wakefield, D. H., Klein, J. J., Wolff, J. A., & Rozema, D. B. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050067h · Cited by 48
Self-citationBenihoud, K., Esselin, S., Descamps, D., Jullienne, B., Salone, B., Bobé, P., Bonardelle, D., Connault, E., Opolon, P., Saggio, I., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302885 · Cited by 39
Pimm, M. V., Perkins, A. C., Duncan, R., & Ulbrich, K. (1993) · Journal of drug targeting · doi:10.3109/10611869308996068 · Cited by 39
Matsumoto, M., Sakao, Y., & Akira, S. (1998) · International Immunology · doi:10.1093/intimm/10.12.1825 · Cited by 33
Cited by
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123
Knocking down barriers: advances in siRNA delivery
Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115
In vivo genome editing using Staphylococcus aureus Cas9
Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., et al. (2015) · Nature · doi:10.1038/nature14299 · Cited by 2,687
Delivery materials for siRNA therapeutics
Kanasty, R., Dorkin, J. R., Vegas, A., & Anderson, D. (2013) · Nature Materials · doi:10.1038/nmat3765 · Cited by 1,800
Therapeutic siRNA: state of the art
Hu, B., Zhong, L., Weng, Y., Peng, L., Huang, Y., Zhao, Y., & Liang, X.-J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0207-x · Cited by 1,586
Metadata
- Authors
- Rozema, D. B., Lewis, D. L., Wakefield, D. H., Wong, S. C., Klein, J. J., Roesch, P. L., Bertin, S. L., Reppen, T. W., Chu, Q., Blokhin, A. V., Hagstrom, J. E., & Wolff, J. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2007-08-07
- Volume
- 104
- Issue
- 32
- Pages
- 12982-12987
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2048369172
- Cited by
- 658
- References
- 51
- FWCI
- 14.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.